Annual General Meeting Further inquiry note: Stephan Haas Investor Relations/PR Telefon: +49(0)7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade München / free ...
Amstetten/Munich (ots) - For ertex solar tradition is not appropriate with imagination, but rather with the traditional slogan of "no limits". This proves the Austrian solar expert once more at the newly designed booth at Intersolar 2009 in Munich. A photovoltaic façade whit the dimension of 5.7 meters in width and 3.0 meters in height, consisting of four elements (each 1.4 x 3.0 m) shows impressively the feasibility of ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, ...
Further inquiry note: Stephan Haas Phone: +49 (0) 7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse ...
init innovation in traffic systems AG
Further inquiry note: Alexandra Weiß Investor Relations Telefon: +49(0)721 6100-102 E-Mail: aweiss@initag.de Branche: Semiconductors & active components ISIN: DE0005759807 WKN: 575980 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / ...
Ludwigshafen (ots) - In simple terms, behind the glass on the front of a plasma screen you'll find a whole lot of tiny cells that are filled with one of the 'noble' gases, generally neon or xenon. Each of these cells represents a single point - a pixel. If a voltage is applied to the gas, then it ...
Ingelheim, Germany, November 17 (ots/PRNewswire) - - Progress Continues Across Expanding Oncology Pipeline With Two Compounds now in Phase III Clinical Development and a Potential First-in-Class Polo-Like Kinase 1 Inhibitor Soon to Enter Phase II - For non-US Healthcare Media Boehringer Ingelheim has marked a new ...
Ludwigshafen (ots) - After the advent of liquid crystal displays, or LCDs, everybody nowadays has at least heard the term 'liquid crystal'. The high-tech screens are everywhere: in computer monitors, cell phones, digital cameras, and calculators. In entertaining episodes our Chemical Reporter ...
LPKF interviewed by Dr. Kalliwoda Research Further inquiry note: Ulrike Thoms-von Meding LPKF Laser & Electronics AG Tel.: +49(0)5131 7095 326 u.thomsvonmeding@lpkf.de Branche: Semiconductors & active components ISIN: DE0006450000 WKN: 645000 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse ...
Ingelheim, Germany (ots/PRNewswire) - - BI 6727, a Highly Potent and Selective Plk1 inhibitor, Represents Latest Advance in Company's Plk1 Programme - For non-US Healthcare Media Boehringer Ingelheim's most promising new cell cycle kinase inhibitor and potentially first-in-class compound, BI 6727, has shown ...
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 631 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse ...
- Expansion of REIS segment with additional retail properties - Capital commitment of 10 million euro from investors - Significant earnings lift expected from 2009 Further inquiry note: InCity Immobilien AG André Peto Phone: +49 (0) 221 95 27 57 55 a.peto@incity.ag Investor Relations Dariusch Manssuri Phone: +49 (0) 221 91 40 970 dariusch.manssuri@ir-on.com Branche: ...
Ingelheim and Biberach, Germany (ots/PRNewswire) - - Boehringer Ingelheim Oncology Pipeline Advances: Two Leading Compounds are Entering Phase III Trials - Boehringer Ingelheim's Investigational Compound in Development for the Treatment of Pre-Menopausal Women Suffering From Hypoactive Sexual Desire Disorder (HSDD) ...
Ludwigshafen (ots) - If you put the oil and water together in a single glass, then they act like a couple of suspicious neighbors. Each quickly finds its own level - the oil on top and the water below - and has as little interaction with the other as possible. There's a kind of fence between them that each is unable to overcome on its own: this ...
Ludwigshafen (ots) - While taking a walk along the beach, you might have noticed shells that have inner surfaces that shimmer in colorful patterns when they reflect the sunlight. The iridescent substance responsible for it is called nacre, or more commonly: mother-of-pearl. The name says it all, ...
Ludwigshafen (ots) - In this podcast you will learn how organic photovoltaics helps to produce solar cells with completely new qualities. In organic photovoltaics dyes are used that are able to convert light into electrical energy. Due to the extremely thin photovoltaic layer, flexible or even ...
Further inquiry note: Verena Fehling Assistant to the Board / Investor Relations Telefon: +49(0)4102 463-100 E-Mail: Verena.Fehling@baslerweb.com Branche: Semiconductors & active components ISIN: DE0005102008 WKN: 510200 Index: CDAX Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / ...
Ludwigshafen (ots) - In this podcast you will learn how the unique characteristics of liquid salts make ionic liquids so interesting for industry. Ionic liquids are molten salts that are also in a liquid form at room temperature. The unique characteristics of these liquid salts are the very thing that makes ionic liquids so interesting for ...
Further inquiry note: Verena Fehling Assistant to the Board / Investor Relations Telefon: +49(0)4102 463-100 E-Mail: Verena.Fehling@baslerweb.com Branche: Semiconductors & active components ISIN: DE0005102008 WKN: 510200 Index: CDAX Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / ...
Further inquiry note: Stephan Haas Investor Relations Manager Telefon: +49(0)7123 724-137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Düsseldorf / free trade Börse ...
Further inquiry note: Stephan Haas Investor Relations Manager Telefon: +49(0)7123 724-137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse ...
Ingelheim, Germany (ots/PRNewswire) - - For non-US Healthcare Media - Abstract # 163O. von Pawel. Proffered Papers 6 - Advanced NSCLC - Latest Phase II Data for Boehringer Ingelheim's New Cancer Drug in Development Presented Monotherapy treatment with the triple angiokinase inhibitor(1) BIBF 1120 (planned tradename ...
Ingelheim, Germany (ots/PRNewswire) - - Results of 25,620 Patient Study ONTARGET(R) (ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial) Presented Today at the 57th Annual Scientific Session of the American College of Cardiology(1) - For Non-US Healthcare Media The results of the ...
Further inquiry note: ElringKlinger AG Kathrin Müller Tel. +49 (0) 7123/724-631 kathrin.mueller@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 9-month report 19.11.2007 AD-HOC-ANNOUNCEMENT PURSUANT TO SECTION 15 WPHG LPKF Laser & Electronics AG: Strong profitable growth anticipated for 2008 to 2010 The Group generated the following ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 9-month report 08.11.2007 Dettingen/Erms (Germany), November 8, 2007 - - - The ElringKlinger Group succeeded in further expanding both its sales revenues and earnings in the first nine months ...
Joint Press Release Issued by WACKER and SCHOTT - WACKER SCHOTT SOLAR will produce multicrystalline silicon wafers for solar cells - Investment of approx. EUR50 million initially creates 140 new jobs at the Jena site - New production facility expected to reach a capacity of 100 megawatts already by the end of 2008 ots.CorporateNews transmitted by euro adhoc. The ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. professional career Garbsen (euro adhoc) - Garbsen, 4th October 2007 - The Supervisory Board of LPKF Laser & Electronics AG appointed Kai Bentz to the Board of Managing Directors with immediate effect. The 35-year-old graduate economist joined LPKF AG in 2002, and was Group Finance and HR Manager before being promoted to the board. His appointment leads to ...
New Managing Director for French subsidiary ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. professional career Garbsen (euro adhoc) - LPKF has appointed a new Managing Director for LPKF France S.A.R.L., the French subsidiary of LPKF Laser & Electronics AG in Garbsen/Germany, who will take over business on 1 October 2007. Michel Mezri Sandid, an ...
Ingelheim, Germany (ots/PRNewswire) - - New Data on BIBW 2992(i), a Potent, Irreversible, Second-Generation Oral Signal Transduction Inhibitor Provides Glimpse of Next Chapter in Lung Cancer Care - For Non-US Media Boehringer Ingelheim announced today from the 12th World Conference on Lung Cancer (WCLC) that the company plans to commence Phase III ...
